1-thiaspiro<4,5>decane

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 硫杂环戊烷
• 英文名称: 1-thiaspiro<4,5>decane
• 英文别名: 1-Thiaspiro[4.5]decane
• 化学式: C₉H₁₆S
• 分子量: 156.292
• InChiKey: PGMIAWCNBUYMDM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-<3-(1,1-dimethylethylthio)propyl>cyclohexanol 在 mercury(II) diacetate 、 三氟乙酸 作用下， 反应 3.0h， 以79%的产率得到1-thiaspiro<4,5>decane
  参考文献：
  名称：

  3-Lithiopropyl叔丁基硫醚：合成有机化学中的一种新型γ官能化有机锂化合物（d 3-试剂）

  摘要：

  在-78°C下使3-溴或3-氯丙基叔丁基硫醚（1a或1'a）与过量的锂粉和催化量的萘（2.5 mol％）在THF中反应用亲电子试剂（H 2 O，D 2 O，Me 2 S2，CO 2）在相同温度下水解后可得到预期的产物2。或者，该方法可以在Barbier型反应条件下进行[锂化反应亲电子的存在：ME 3的SiCl，卜吨CHO，苯甲醛中，Me 2 CO，（CH 2）4 CO，（CH 2）5 CO，PhCOMe，c -C 3 H 5 COPh]，并在0°C下使用DTBB作为芳烃催化剂。去叔产品-butylation 2与汞（II）乙酸盐和取决于起始硫醚的结构氢硫酸的产率不同硫化衍生物。

  DOI：

  10.1016/0040-4020(95)00749-x

文献信息

• [EN] PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS CONTENANT DE LA PIPÉRIDINE ET LEURS UTILISATIONS
  申请人：ARRAY BIOPHARMA INC

  公开号：WO2010080864A1

  公开（公告）日：2010-07-15

  A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I) wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.

  一种预防和/或治疗代谢性疾病、脑血管疾病等的方法，包括向哺乳动物施用化合物的有效量，其化学式为(I)，其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂合物或前药。以及化学式(I-1)的新化合物：其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂合物或前药具有抗糖尿病作用和神经保护作用。因此，化合物(I)和化合物(I-1)在预防和/或治疗代谢性疾病如糖尿病、脑血管疾病如中风等方面是有用的。
• NITRILES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1724264A1

  公开（公告）日：2006-11-22

  The present invention relates to a compound of formula (I) wherein Y and Z each is independently N or C; ring A is a carbocyclic group or a heterocyclic group; ring B is a heterocyclic group containing at least one nitrogen atom; R is a hydrogen atom, a substituent, etc,; n is 0, or an integer of from 1 to 10, a salt thereof, a solvate thereof, or an N-oxide thereof, or a prodrug thereof. The compound of formula (I), a salt thereof, a solvate thereof, or an N-oxide thereof, or a prodrug thereof has an inhibitory activity against cysteine protease, and it is useful for the prophylaxis and/or treatment of a cysteine protease-related disease such as osteoporosis, etc.

  本发明涉及一种具有以下式（I）的化合物，其中Y和Z各自独立地为N或C；环A为碳环基团或杂环基团；环B为含有至少一个氮原子的杂环基团；R为氢原子、取代基等；n为0，或为1至10的整数，其盐、溶剂合物、N-氧化物或前药。具有式（I）的化合物，其盐、溶剂合物、N-氧化物或前药对半胱氨酸蛋白酶具有抑制活性，对于预防和/或治疗半胱氨酸蛋白酶相关疾病如骨质疏松症等是有用的。
• Nitrogenous heterocyclic compounds and medical use thereof
  申请人：Takahashi Kanji

  公开号：US20070010529A1

  公开（公告）日：2007-01-11

  The present invention relates to a compound represented by formula (I): (wherein all the symbols have the same meanings as defined in the above description) and a production method and use thereof. The compounds represented by formula (I), or its salt, N-oxide or solvate, or a prodrug thereof have p38 MAP kinase inhibitory activity, and are useful in the prevention and/or treatment of those diseases that are supposedly caused or deteriorated by abnormal production of cytokines including inflammatory cytokine or chemokine, or by over response thereto, namely cytokine-mediated diseases such as inflammatory diseases, respiratory diseases, cardiovascular disease, central nervous system diseases, and the like.

  本发明涉及一种由以下式表示的化合物：(其中所有符号的含义与上述描述中定义的相同)，以及其生产方法和用途。由式(I)表示的化合物，或其盐、N-氧化物或溶剂合物，或其前药，在p38 MAP激酶抑制活性方面具有作用，并且在预防和/或治疗那些据称由细胞因子异常产生或恶化引起，或由过度反应引起的疾病方面有用，即细胞因子介导的疾病，如炎症性疾病、呼吸系统疾病、心血管疾病、中枢神经系统疾病等。
• NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1741702A1

  公开（公告）日：2007-01-10

  The present invention provides a compound having p38 MAP kinase inhibitory activity. Because of having p38 MAP kinase inhibitory activity, the compounds represented by the formula (I): wherein each symbol is as defined in the description, salts thereof, N-oxides thereof, solvates thereof, or prodrugs thereof are useful in preventing and/or treating diseases that are supposedly caused or deteriorated by abnormal production of cytokines including inflammatory cytokines or chemokines, or by overresponse thereto, namely cytokine-mediated diseases such as inflammatory diseases, respiratory diseases, cardiovascular diseases and bone diseases.

  本发明提供了一种具有p38 MAP激酶抑制活性的化合物。由于具有p38 MAP激酶抑制活性，由式(I)所表示的化合物：其中每个符号如描述中所定义，其盐、N-氧化物、溶剂合物或前药在预防和/或治疗据称由细胞因子异常产生或恶化引起的疾病方面具有用处，包括炎症性细胞因子或趋化因子，或由对其过度反应引起的疾病，即细胞因子介导的疾病，如炎症性疾病、呼吸系统疾病、心血管疾病和骨疾病。
• Anti-Cancer Agents Synthesized Based On Miliusane Compounds
  申请人：HONG KONG BAPTIST UNIVERSITY

  公开号：US20130324580A1

  公开（公告）日：2013-12-05

  The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to new anticancer agents based on miliusane compounds. The present invention also includes its preparation and application method for treating cancer.

  本发明属于制药和化工行业。具体来说，本发明涉及基于米利乌烷化合物的新型抗癌药物。本发明还包括其制备方法和治疗癌症的应用方法。

表征谱图